Showing posts with label cefuroxime. Show all posts
Showing posts with label cefuroxime. Show all posts

Friday, May 17, 2013

HPLC ASSAY METHOD FOR CEFUROXIME


Chromatographic System :
Column               : 25cm x 4.6mm, packed with particles of silica(5µm)
Flow rate             : 1.2ml / minute , so that the resolution factors between the peaks  corresponding to the Cefuroxime axetil diastereoisomers A & B  in solution(4)and between the peaks corresponding to Cefuroxime axetil diastereoisomer A & the Cefuroxime axetil A³ -isomer in  solution (2) are each not less than 1.5.
Wavelength                   : 278nm
Temperature       :Ambient
Injection volume : 20µL
Mobile Phase       : A mixture of 38 volumes of Methanol & 62 volumes of
                               0.2M Ammonium dihydrogen orthophosphate.
 Solution (1) :- Disperse 10 tablets in 0.2M Ammonium Dihydrogen Orthophosphate
previously adjusted to pH 2.4 with Orthophosphoric acid using 10ml per gm of the stated content of cefuroxime . Immediately add sufficient methanol to produce a solution containing the equivalent to 0.5%w/v of cefuroxime and shake vigorously.
Filter and dilute a quantity of the filtrate with sufficient mobile phase to produce a
solution containing the equivalent to 0.025% w/v of cefuroxime.
Solution (2) :- Heat a quantity of solution(1) at 600 C for 1hour or until sufficient impurities (   0   -isomers) have been generated.
 Solution (3) :- Expose  a quantity of solution(1) to ultraviolet light (254nm) for            24 hours or until sufficient impurities (E-isomers) have been generated.             Solution (4) contains 0.03% w/v of Cefuroxime Axetil CRS in mobile phase.
  All solutions containing Cefuroxime Axetil, if not to be used for immediate
  analysis, should be stored in the dark at a temperature 2º & 8º before analysis.

The retention times relative to Cefuroxime axetil diastereoisomer A are approximately 0.9 for Cefuroxime axetil diastereoisomer B , 1.2 for the Cefuroxime
axetil  A³-isomers and 1.7 & 2.1 for E-isomers .The relative standard deviation for the
response factor of Cefuroxime axetil for replicate injections of solution (1) is not more than 2.0%.
Calculate the content of C20H22N4O10S as the sum of the areas of the two peaks  corresponding to diastereoisomers A & B of Cefuroxime axetil using the declared
Content of C20H22N4O10S in Cefuroxime axetil CRS. Each mg of Cefuroxime axetil
Is equivalent to 0.8313mg Cefuroxime.